Elevated levels of the second messenger c‐di‐ GMP contribute to antimicrobial resistance of P seudomonas aeruginosa
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary: Biofilms are highly structured, surface‐associated communities. A hallmark of biofilms is their extraordinary resistance to antimicrobial agents that is activated during early biofilm development of P seudomonas aeruginosa and requires the regulatory hybrid SagS and BrlR , a member of the MerR family of multidrug efflux pump activators. However, little is known about the mechanism by which SagS contributes to BrlR activation or drug resistance. Here, we demonstrate that Δ sagS biofilm cells harbour the secondary messenger c‐di‐ GMP at reduced levels similar to those observed in wild‐type cells grown planktonically rather than as biofilms. Restoring c‐di‐ GMP levels to wild‐type biofilm‐like levels restored brlR expression, DNA binding by BrlR , and recalcitrance to killing by antimicrobial agents of Δ sagS biofilm cells. We likewise found that increasing c‐di‐ GMP levels present in planktonic cells to biofilm‐like levels (≥ 55 pmol mg −1 ) resulted in planktonic cells being significantly more resistant to antimicrobial agents, with increased resistance correlating with increased brlR , mexA , and mexE expression and BrlR production. In contrast, reducing cellular c‐di‐ GMP levels of biofilm cells to ≤ 40 pmol mg −1 correlated with increased susceptibility and reduced brlR expression. Our findings suggest that a signalling pathway involving a specific c‐di‐ GMP pool regulated by SagS contributes to the resistance of P . aeruginosa biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the level of c-di-GMP is elevated in biofilm cells in comparison to in planktonic cells.”
From Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics (2019) · cites this paper as Gupta et al., 2014
In the citing paper
“Artificial increase of the c-di-GMP level to “biofilm” levels in planktonic cultures was found to lead to a higher tolerance of the bacterial cells to antibiotics.”
From Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics (2019) · cites this paper as Gupta et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Resistance, indicated by an increased minimum inhibitory concentration (MIC), refers to the ability of a microorganism to grow in the presence of an elevated level of an antimicrobial agent, to which they were once sensitive, due to mechanisms such as the presence of plasmid-borne resistance markers or resistance conf…”
BackgroundDetermination of minimum inhibitory concentrations
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.5 · Cited by 4,129 · cited 1×
“The method was adapted from Andrews (Andrews, 2001).”
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691 · cited 2×
“Briefly, total cell extracts from biofilms were obtained by sonication as previously described (Sauer et al., 2002) followed by centrifugation for 2 min at 21 200 g to pellet unbroken cells.”
MethodSelf-citationProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997 · cited 1×
“(Drenkard and Ausubel, 2002) reported a link between phenotypic variants, persistent 500 K.”
BackgroundTseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466 · cited 1×
“aeruginosa cells, with enhanced matrix production offering protection from environmental factors and antimicrobials including the aminoglycoside tobramycin (Khan et al., 2010; Colvin et al., 2011; Ma et al., 2012; Billings et al., 2013; Tseng et al., 2013).”
BackgroundPersistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Research works printed but not linked: 61
- 10.1128/JB.01369-06 · DOI · Paper page
- 10.1128/JB.00707-08 · DOI · Paper page
- 10.1128/AEM.01233-10 · DOI · Paper page
- 10.1128/JB.00975-09 · DOI · Paper page
- 10.1128/JB.05346-11 · DOI · Paper page
- Basu Roy A. Petrova O.E. andSauer K. (2013)Extraction and quantification of cyclic di‐GMP fromPseudomonas aeruginosa.bio‐protocol[WWW document]. URLhttp://www.bio‐protocol.org/wenzhang.aspx?id=828 · doi:10.21769/bioprotoc.828
- 10.2144/00295bm04 · DOI · Paper page
- 10.1371/journal.ppat.1003526 · DOI · Paper page
- 10.1111/j.1365-2958.2009.06795.x · DOI · Paper page
- 10.1128/AAC.02499-12 · DOI
- 10.1371/journal.ppat.1001264 · DOI · Paper page
- 10.1126/science.284.5418.1318 · DOI · Paper page
- 10.1099/mic.0.27099-0 · DOI · Paper page
- 10.1073/pnas.76.4.1648 · DOI · Paper page
- 10.1016/S0065-2911(02)46005-5 · DOI · Paper page
- 10.1128/JB.00732-13 · DOI · Paper page
- 10.1086/598644 · DOI · Paper page
- 10.1016/S0378-1119(98)00130-9 · DOI · Paper page
- 10.1006/plas.1999.1441 · DOI · Paper page
- 10.1073/pnas.1217993109 · DOI · Paper page
- 10.1172/JCI30783 · DOI · Paper page
- 10.1016/S0378-1097(03)00856-5 · DOI · Paper page
- Khan W., 2010, Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide, Int Microbiol, 13, 207
- 10.1111/j.1365-2958.2004.04253.x · DOI · Paper page
- 10.1021/bp000117r · DOI
- 10.1128/JB.00586-07 · DOI · Paper page
- Kulasekara H., 2006, Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis‐(3′–5′)‐cyclic‐GMP in virulence, Proc Natl Acad Sci USA, 103, 2839, 10.1073/pnas.0511090103 · DOI · Paper page
- 10.1128/AAC.45.4.999-1007.2001 · DOI · Paper page
- 10.1007/978-3-540-75418-3_6 · DOI · Paper page
- 10.1128/JB.00765-12 · DOI · Paper page
- 10.1128/JB.00318-13 · DOI · Paper page
- 10.1128/JB.01202-06 · DOI · Paper page
- 10.1111/j.1574-695X.2012.00934.x · DOI · Paper page
- 10.1038/nature02122 · DOI · Paper page
- 10.1128/JB.00585-07 · DOI · Paper page
- 10.1093/jac/48.6.793 · DOI
- 10.1128/JB.00599-06 · DOI · Paper page
- 10.1080/09674845.2007.11732766 · DOI
- 10.1016/S0378-1119(98)00601-5 · DOI · Paper page
- 10.1126/science.1211037 · DOI · Paper page
- 10.1016/0003-2697(77)90043-4 · DOI · Paper page
- 10.1371/journal.ppat.1000668 · DOI · Paper page
- 10.1128/JB.00387-10 · DOI · Paper page
- 10.1128/JB.00305-11 · DOI · Paper page
- 10.1073/pnas.1207832109 · DOI · Paper page
- 10.1111/j.1365-2958.2011.07733.x · DOI
- 10.1111/mmi.12018 · DOI · Paper page
- 10.1016/j.mib.2006.02.010 · DOI
- 10.1111/j.1365-2958.2005.04697.x · DOI · Paper page
- 10.1128/JB.183.22.6579-6589.2001 · DOI · Paper page
- 10.1128/JB.186.21.7312-7326.2004 · DOI · Paper page
- 10.1016/0378-1119(95)00055-B · DOI · Paper page
- 10.1111/j.1365-2958.2004.04206.x · DOI · Paper page
- 10.1038/nbt1183-784 · DOI · Paper page
- 10.1128/JB.187.23.8114-8126.2005 · DOI · Paper page
- 10.1128/JB.183.23.6746-6751.2001 · DOI · Paper page
- 10.1128/JB.00119-09 · DOI · Paper page
- 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
- 10.1046/j.1365-2958.2003.03740.x · DOI · Paper page
- 10.1128/AAC.00343-07 · DOI
- 10.1093/nar/gkn861 · DOI · Paper page
Cited by
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 2,031
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 842
Metadata
- Authors
- Gupta, K., Liao, J., Petrova, O. E., Cherny, K. E., & Sauer, K.
- Affiliations
- Department of Biological Sciences Binghamton University Binghamton NY 13902 USA
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2014-04-09
- Volume
- 92
- Issue
- 3
- Pages
- 488-506
- ISSN
- 0950-382X
- 1365-2958
- Cited by
- 91
- References
- 9
- Language
- en
- Funders
- Institut national de la santé et de la recherche médicale (R01 AI080710)
- U.S. Department of Defense (W81XWH-12-2-0063)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.